Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
RYZODEG Drug Insight and Market Forecast − 2032
... of the RYZODEG for type 1 diabetes mellitus in the 6MM, i.e., EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report ... Read More
-
ITI-1000 Emerging Drug Insight and Market Forecast − 2032
... picture of the ITI-1000 for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Night Vision Disturbances - Market Insight, Epidemiology And Market Forecast - 2032
... Night Vision Disturbance in the 7MM is expected to increase, driven by better diagnosis and launch of emerging therapies. DelveInsight’s analyst projects that among the total cases of NVD in 7MM approximately 44% of cases ... Read More
-
Niemann-Pick Disease Type C - Market Insight, Epidemiology And Market Forecast - 2032
... accounting for approximately USD 9 million, expected to increase by 2032. There are 787 diagnosed cases of Niemann–Pick Disease Type C (NPC) in the 7MM in 2022, of which 42% of patients are attributed to ... Read More
-
SAB-176 Emerging Drug Insight and Market Forecast − 2032
... of the SAB-176 for seasonal influenza in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
JORVEZA Drug Insight and Market Forecast − 2032
... the JORVEZA for EoE in the 5MM, i.e., EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 –2032 is provided in this report along with a detailed description of ... Read More
-
Berubicin Emerging Drug Insight and Market Forecast − 2032
... picture of the berubicin for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
GLIOVAC Emerging Drug Insight and Market Forecast − 2032
... picture of the GLIOVAC for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Pegargiminase Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the pegargiminase for MPM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
-
Ipilimumab + nivolumab Drug Insight and Market Forecast − 2032
... seven major markets. A detailed picture of the Ipilimumab + nivolumab for MPM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study ... Read More
-
KEYTRUDA Drug Insight and Market Forecast − 2032
... of the KEYTRUDA for MPM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this report ... Read More
-
LANTIDRA Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the LANTIDRA for type 1 diabetes mellitus in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 ... Read More
-
Intrahepatic Cholangiocarcinoma- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Intrahepatic ... Read More
-
Cendakimab Emerging Drug Insight and Market Forecast − 2032
... picture of the cendakimab for EoE in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Nausea and Vomiting Induced by Motion Sickness - Market Insight, Epidemiology And Market Forecast - 2032
... by motion sickness in the US. Nausea and vomiting are well-recognized phenomena during travel, making it easier for individuals to recognize and identify the condition. There is no effective therapy to treat nausea and vomiting ... Read More
-
Pemetrexed + cisplatin Drug Insight and Market Forecast − 2032
... seven major markets. A detailed picture of the pemetrexed + cisplatin for MPM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study ... Read More
-
VBI-1901 Emerging Drug Insight and Market Forecast − 2032
... picture of the VBI-1901 for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
MDNA55 Emerging Drug Insight and Market Forecast − 2032
... picture of the MDNA55 for GBM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
CARTISTEM Drug Insight and Market Forecast − 2032
... for osteoarthritis in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, along with Canada, and Korea for the study period 2019 –2032 is provided in this report ... Read More
-
TTHX 1114 Emerging Drug Insight and Market Forecast − 2032
... seven major markets. A detailed picture of the TTHX 1114 for FECD in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period ... Read More
-
MTG201 + nivolumab Emerging Drug Insight and Market Forecast − 2032
... in the seven major markets. A detailed picture of the MTG201 + nivolumab for MPM in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for ... Read More
-
Digital Health Market: Focus on Digital Therapeutics (3rd Edition), 2023-2035
... prevent a disease. Such solutions usually employ evidence based and clinically validated software or technologies, in order to capture real-time patient data and provide improved curative response. Considering the ongoing digitization efforts and transformation of ... Read More
-
Synthetic Biology: Protein Design and Engineering Market- Focus on Services and Technology Providers – Market Distribution by Type of Protein Engineering Approach Used (Rational Designing, Directed Evolution and Semi-Rational Designing), Type of Protein (Antibodies, Peptides, Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), Type of End User (Pharma / Biotech Firms, CROs and Research / Academic Institutes) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa and Rest of the World)): Industry Trends and Global Forecasts, 2021-2035
... Enzymes, Vaccines and Others), Type of Application (Therapeutics and Diagnostics), Type of End User (Pharma / Biotech Firms, CROs and Research / Academic Institutes) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle ... Read More
-
Global Anti-Epileptic Drugs Market: Analysis By Drug Generation (First Generation Second Generation, and Third Generation), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Providers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... of COVID-19 and Forecast up to 2028 The global Anti-Epileptic Drugs (AEDs) market in 2022 stood at US$9.39 billion and is likely to reach US$11.47 billion by 2028. Anti-Epileptic Drugs (AEDs) represent a non-invasive imaging ... Read More
-
Biophotonics Market Size, Share & Trends Analysis Report By Technology (In-Vitro, In-Vivo), By Application (See-Through imaging, Microscopy, Inside Imaging), By End-use (Tests and Components, Medical Therapeutics), By Region, And Segment Forecasts, 2023 -
... Market Growth & Trends The global biophotonics market size is expected to reach USD 134.83 billion by 2030, registering a CAGR of 10.3% from 2023 to 2030, according to a new report by Grand View ... Read More
Research Assistance
